Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).

Details

Language :

English

ISSN :

00034967

Volume :

76

Issue :

4

Database :

Complementary Index

Journal :

Annals of the Rheumatic Diseases

Publication Type :

Academic Journal

Accession number :

121818504

Full Text :

https://doi.org/10.1136/annrheumdis-2016-209821